They work by regulating appetite, improving fat metabolism, enhancing energy use, and preserving lean muscle
In a recent review published in the journal Obesity Pillars , a team of researchers collate and narratively review the literature on the dietary impacts of obesity or type 2 diabetes (T2D) patients undergoing glucagon-like peptide receptor agonists (GLP-1RAs) or glucose-dependent insulinotropic polypeptide/glucagon-like peptide receptor agonists (GIP/GLP-1RAs) clinical interventions
Key Takeaways NAD+ boosts energy production within cells through mitochondria B12 helps your body make red blood cells and supports nerve function
[2] Hydrogen peroxide is also damaging and is degraded by other enzymes such as catalase
A consistent pattern emerges in phenotypes with a high metabolic burden, such as obesity and IGT or pre-diabetes, improvements in fasting glucose, OGTT curves, and HbA1c are more pronounced, with some subjects even reverting from IGT to normoglycemia